Inari Medical Stock Net Income
| NARIDelisted Stock | USD 79.97 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Inari Medical's long-term financial health and intrinsic value.
Inari |
Inari Medical Company Net Income Analysis
Inari Medical's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Inari Medical Net Income | (1.64 M) |
Most of Inari Medical's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Inari Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Inari Medical reported net income of (1.64 Million). This is 100.48% lower than that of the Health Care Equipment & Supplies sector and 100.69% lower than that of the Health Care industry. The net income for all United States stocks is 100.29% higher than that of the company.
Inari Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Inari Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Inari Medical could also be used in its relative valuation, which is a method of valuing Inari Medical by comparing valuation metrics of similar companies.Inari Medical is currently under evaluation in net income category among its peers.
Inari Fundamentals
| Return On Equity | -0.18 | |||
| Return On Asset | -0.0321 | |||
| Profit Margin | (0.14) % | |||
| Operating Margin | (0.04) % | |||
| Current Valuation | 4.6 B | |||
| Shares Outstanding | 58.56 M | |||
| Shares Owned By Insiders | 8.99 % | |||
| Shares Owned By Institutions | 95.50 % | |||
| Number Of Shares Shorted | 2.48 M | |||
| Price To Earning | 275.35 X | |||
| Price To Book | 10.77 X | |||
| Price To Sales | 8.15 X | |||
| Revenue | 493.63 M | |||
| Gross Profit | 498.76 M | |||
| EBITDA | 15.19 M | |||
| Net Income | (1.64 M) | |||
| Cash And Equivalents | 330.5 M | |||
| Cash Per Share | 6.19 X | |||
| Total Debt | 32.05 M | |||
| Debt To Equity | 0.07 % | |||
| Current Ratio | 10.04 X | |||
| Book Value Per Share | 7.44 X | |||
| Cash Flow From Operations | 35.93 M | |||
| Short Ratio | 0.54 X | |||
| Earnings Per Share | (1.35) X | |||
| Price To Earnings To Growth | (1.88) X | |||
| Target Price | 78.03 | |||
| Number Of Employees | 1.3 K | |||
| Beta | 1.03 | |||
| Market Capitalization | 4.68 B | |||
| Total Asset | 674.24 M | |||
| Retained Earnings | (48.49 M) | |||
| Working Capital | 159.22 M | |||
| Net Asset | 674.24 M |
About Inari Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Inari Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inari Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inari Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Inari Stock
If you are still planning to invest in Inari Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Inari Medical's history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |